---
title: "Arunjyoti Bio Ventures Ltd (530881) — Share Price, Financials & Analysis"
symbol: "530881"
company: "Arunjyoti Bio Ventures Ltd"
canonical: "https://tapetide.com/stocks/530881"
isin: "INE485K01022"
nse_symbol: "ARUNJYOTHIBIOVENTURESLTD"
bse_code: "530881"
sector: "Financial Services"
industry: "Other Financial Services"
market_cap_cr: 85.54
generated_at: "2026-09-13T19:51:51.188Z"
---

# Arunjyoti Bio Ventures Ltd (530881)

Canonical page: https://tapetide.com/stocks/530881

## Company

- **NSE Symbol:** ARUNJYOTHIBIOVENTURESLTD
- **BSE Code:** 530881
- **ISIN:** INE485K01022
- **Sector:** Financial Services
- **Industry:** Other Financial Services
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **CEO:** Mr. Nadimpalli Vishal
- **Employees:** 166
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** abvl.co.in

## About

Incorporated in 1986, Arunjyoti Bio Ventures Ltd is engaged in providing co-packing services.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:52:59.653832Z.

- **Market Cap:** ₹85.54 Cr
- **Classification:** Microcap
- **P/E (reported):** -14.4
- **EPS (TTM):** ₹-0.33
- **EPS (reported):** ₹0.7
- **Book Value:** ₹1.54
- **Price to Book:** 3
- **Dividend Yield:** 0%
- **ROE:** -15.8%
- **ROCE:** -7.59%
- **Debt to Equity:** 0.78
- **Revenue (yearly):** ₹27.9 Cr
- **Net Income:** ₹-4.5 Cr
- **EBITDA:** ₹3 Cr
- **52-Week High:** ₹12.71
- **52-Week Low:** ₹4
- **RSI (14):** 33.57

## Tapetide Score

- **Score:** 37 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 8.7 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 1.1 | 9% |
| growth | 46.99 | 9% |
| momentum | 9.15 | 12% |
| ownership | 50 | 24% |
| quality | 42.73 | 22% |
| valuation | 43.55 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 2.95 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -4.58% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 539.51% | 64.18% | — |
| ebitda margin growth | 0% | -42.68% | -21.44% | 354.43% |
| net income growth | 0% | — | — | — |
| revenue growth | 100% | -1.06% | 152% | 38% |
| roce | — | -267.55% | -568.52% | 0.58% |
| roe | — | — | -12.13% | -662.28% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3.14 | 5.79 | 8.7 | 10.1 | 6.35 | 6.15 | 5.28 | 8.71 | 5.34 | 6.47 | 7.24 | 8.2 |
| Expenses | 3.49 | 3.97 | 7.46 | 6.56 | 5.57 | 5.81 | 4.94 | 5.11 | 5.08 | 5.05 | 9.61 | 6.12 |
| Operating Profit | -0.35 | 1.82 | 1.24 | 3.54 | 0.78 | 0.34 | 0.34 | 3.6 | 0.26 | 1.42 | -2.37 | 2.08 |
| OPM % | -11.15 | 31.43 | 14.25 | 35.05 | 12.28 | 5.53 | 6.44 | 41.33 | 4.87 | 21.95 | -32.73 | 25.37 |
| Other Income | 0.07 | 0 | -0.04 | 0.1 | 0.11 | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | -2.66 | 0.02 |
| Interest | 0.57 | 0.71 | 0.8 | 0.67 | 0.67 | 0.65 | 0.59 | 0.62 | 0.51 | 0.52 | 0.4 | 0.44 |
| Depreciation | 0.54 | 0.67 | 0.81 | 0.72 | 0.74 | 0.78 | 0.8 | 0.82 | 0.83 | 0.84 | 0.87 | 0.84 |
| Profit before tax | -1.39 | 0.44 | -0.41 | 2.25 | -0.52 | -1.03 | -1.04 | 2.17 | -1.07 | 0.07 | -6.3 | 0.82 |
| Tax % | -0.72 | 163.64 | -407.32 | 24.89 | -59.62 | -14.56 | 91.35 | 5.53 | 14.02 | 42.86 | -14.29 | 24.39 |
| Net Profit | -1.37 | -0.28 | 1.26 | 1.69 | -0.22 | -0.89 | -1.99 | 2.05 | -1.23 | 0.05 | -5.4 | 0.61 |
| EPS in Rs | -0.07 | -0.02 | 0.07 | 0.09 | -0.01 | -0.05 | -0.11 | 0.11 | -0.07 | 0 | -0.29 | 0.03 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.05 | 3.72 | 6.74 | 5.51 | 2.94 | 1.74 | 20.43 | 27.88 | 27.75 | 27.25 |
| Expenses | 0.28 | 3.68 | 6.61 | 5.41 | 3.14 | 1.57 | 17.65 | 22.87 | 24.74 | 25.86 |
| Operating Profit | -0.23 | 0.04 | 0.13 | 0.1 | -0.2 | 0.17 | 2.78 | 5.01 | 3.01 | 1.39 |
| OPM % | -460 | 1.08 | 1.93 | 1.81 | -6.8 | 9.77 | 13.61 | 17.97 | 10.85 | 5.1 |
| Other Income | 0 | 0 | 0 | 0 | 0.28 | 0 | 0.04 | 0.28 | -2.74 | -2.62 |
| Interest | 0.01 | 0 | 0 | 0.01 | 0 | 0.01 | 2.11 | 2.59 | 2.05 | 1.87 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 2.01 | 3.05 | 3.36 | 3.38 |
| Profit before tax | -0.24 | 0.04 | 0.13 | 0.09 | 0.08 | 0.16 | -1.3 | -0.35 | -5.14 | -6.48 |
| Tax % | 0 | 0 | 23.08 | 22.22 | 25 | 25 | -73.08 | -17.14 | -11.67 | — |
| Net Profit | -0.25 | 0.04 | 0.11 | 0.07 | 0.06 | 0.12 | -0.35 | -0.28 | -4.54 | -5.97 |
| EPS in Rs | -0.01 | 0 | 0.01 | 0 | 0 | 0.01 | -0.02 | -0.02 | -0.24 | -0.33 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 | 18.64 | 18.64 |
| Reserves | -0.1 | -0.34 | -0.3 | -0.19 | -0.13 | -0.07 | 0.04 | -0.3 | 14.62 | 10.08 |
| Borrowings | 0.19 | 0.19 | 0 | 0 | 0 | 0 | 32.27 | 51.4 | 26.21 | 22.27 |
| Other Liabilities | 17.7 | 8.36 | 3.71 | 4.02 | 2.77 | 0.09 | 1.53 | 0.82 | 1.91 | 3.17 |
| Total Liabilities | 19.86 | 10.28 | 5.48 | 5.9 | 4.71 | 2.09 | 35.91 | 53.99 | 61.38 | 54.16 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.5 | 43.5 | 45.59 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 19.19 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 19.86 | 10.28 | 5.48 | 5.9 | 4.71 | 2.09 | 16.72 | 13.49 | 17.88 | 8.57 |
| Total Assets | 19.86 | 10.28 | 5.48 | 5.9 | 4.71 | 2.09 | 35.91 | 53.99 | 61.38 | 54.16 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 3.09 | -2.71 | 0.77 | -0.31 | -0.78 | -13.07 | 6.31 | 1.62 | 10.36 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | 0 | -19.19 | -22.58 | -5.76 | -4.84 |
| Cash from Financing Activity | 0.15 | 0 | -0.19 | 0 | 0 | 0 | 32.27 | 16.33 | 4.65 | -5.99 |
| Net Cash Flow | 0.15 | 3.09 | -2.9 | 0.77 | -0.31 | -0.78 | 0.02 | 0.06 | 0.51 | -0.47 |
| Free Cash Flow | 0 | 3.09 | -2.71 | 0.77 | -0.31 | -0.78 | -32.26 | -16.31 | -4.42 | 7.55 |
| CFO/OP | 0 | -1365 | -6775 | 615 | -280 | 390 | -7688 | 227 | 39 | 348 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 159.68 | 32923 | 231.56 | 144.59 | 121.89 | 67.04 | 163.62 | 48.77 | 51.97 | 50.51 |
| Inventory Days | — | — | 61.61 | 1.8 | 2.34 | 0 | 214.13 | 125.52 | 175.37 | — |
| Days Payable | — | — | 245.27 | 130.66 | 102.39 | — | 0 | 16.71 | 100.52 | — |
| Cash Conversion Cycle | 159.68 | 32923 | 47.9 | 15.73 | 21.84 | 67.04 | 377.75 | 157.59 | 126.83 | 50.51 |
| Working Capital Days | 2.14 | -22703 | -6.87 | -40.07 | -23.85 | 122.91 | 834.89 | 109.88 | 47.26 | -102.73 |
| ROCE % | 12.09 | -11.27 | 2.17 | 7.12 | 5.24 | 4.06 | 0.93 | 1.85 | 3.98 | -0.42 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 48.97% | 48.97% | 48.97% | 61.79% | 61.79% | 61.05% | 47.64% | 47.64% | 47.64% | 47.64% | 47.64% | 47.64% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 49.79% | 49.42% | 49% | 36.45% | 36.1% | 35.88% | 49.59% | 49.32% | 49.08% | 49.36% | 49.04% | 49.15% |
| Others | 1.24% | 1.61% | 2.03% | 1.76% | 2.11% | 3.07% | 2.78% | 3.04% | 3.29% | 3.01% | 3.32% | 3.21% |
| No. of Shareholders | 703 | 750 | 740 | 1168 | 1655 | 2793 | 5122 | 5439 | 5321 | 5215 | 5634 | 20483 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 4.72 | Sell |
| EMA (10) | 4.73 | Sell |
| SMA (20) | 4.86 | Sell |
| EMA (20) | 4.84 | Sell |
| SMA (50) | 5.19 | Sell |
| EMA (50) | 5.16 | Sell |
| SMA (100) | 5.64 | Sell |
| EMA (100) | 5.7 | Sell |
| SMA (200) | 6.77 | Sell |
| EMA (200) | 6.59 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 31.35 | Neutral |
| MACD (12,26,9) | -0.15 | Sell |
| Stochastic (14,3,3) | 51.8 | Neutral |
| ADX (14) | 27.67 | Buy |
| Williams %R (14) | -50.45 | Neutral |
| ATR (14) | 0.27 | High Volatility |
| ROC (12) | -8.63 | Sell |
| Stoch RSI (14) | 37.16 | Neutral |
| UO (7,14,28) | 48.37 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Change of Company Name](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c702bbe4-6248-4911-abc9-f3621239b20e.pdf) |
| 2026-08-12 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ce148c3-4473-478d-a01a-ca4444bf51c5.pdf) |
| 2026-08-12 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ed8ac31-8b55-4d87-b00f-a470960bb183.pdf) |
| 2026-07-20 | [Notice Of AGM For The FY 2025-26 Scheduled To Be Held On 12.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3eb6f4b-fe4a-4b7a-b5ae-8f8f1e3d06ea.pdf) |
| 2026-07-20 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6fb6fdb-c37f-4a09-9c71-ece7499b526c.pdf) |
| 2026-07-09 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70e1c327-a136-4e4f-a83d-5d7e1ae142b7.pdf) |
| 2026-07-08 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=602616e2-e18b-4755-a359-e20a77e94598.pdf) |
| 2026-07-04 | [Board Meeting Intimation for Board Meeting To Be Held On 09.07.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=042ccc1e-cbc4-4163-8a03-b8f282057c64.pdf) |
| 2026-06-24 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32e2583f-3c6b-486f-b289-9da7c35f37e7.pdf) |
| 2026-05-26 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8163866-aa81-4b52-b3cf-c29fce4dadc3.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-09 | [Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended 30.06.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f90cb04-4a8f-4a0f-be9e-03b6c17b6e3f.pdf) |
| 2026-05-13 | [Audited Financial Statements For The Quarter And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7c162a1-425f-423e-a047-a4cdf4869ddc.pdf) |
| 2026-02-03 | [Unaudited Financial Results Along With Limited Review Report For The Quarter Ended 31.12.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17d89cfd-bdd2-407b-b824-b80637891dca.pdf) |
| 2025-01-27 | [Results For The Quarter Ended 31.12.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e97edd7-7919-40bf-a5a0-dd80c22388d0.pdf) |
| 2024-11-12 | [Unaudited Results For The Quarter Ended 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68e0a0da-da71-4ffb-b9db-9d95c5a0ba48.pdf) |
| 2024-08-12 | [Unaudited Financial Results For Quarter Ended 30.6.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=262d1b9d-6117-43ce-a2f4-9c77117715dc.pdf) |
| 2024-05-30 | [Audited Financial Results For The Quarter And Year Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6aafb757-cc63-44a5-ac5b-676260f12e28.pdf) |
| 2024-02-10 | [Results For The Quarter Ended 31.12.2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f86e7ed7-284a-4401-a44e-4f2f0951b200.pdf) |
| 2023-10-31 | [Results- Financial Results For Quarter Ended 30.09.2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7dc8916a-0222-4b7f-aada-f28ee618a5b1.pdf) |
| 2023-07-25 | [Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48754869-e58a-4c94-9c5e-7874f28ab922.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 30 Jan - Board meeting on 03-Feb-2026 to consider unaudited Q3 results for quarter ended 31.12.2025. | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 03.02.2026 30 Jan - Board meeting on 03-Feb-2026 to consider unaudited Q3 results for quarter ended 31.12.2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a9a1f4ff-3336-4640-8a7a-f919c1f1a728.pdf) |
| 30 Apr - Arunjyoti Bio Ventures says it does not qualify as a Large Corporate; FY2026-27 initial disclosure not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Arunjyoti Bio Ventures says it does not qualify as a Large Corporate; FY2026-27 initial disclosure not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cd751eb1-434a-41f6-aca8-a212a20d1dc8.pdf) |
| 30 Apr - Arunjyoti Bio Ventures says it does not qualify as a Large Corporate; FY2026-27 initial disclosure not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Arunjyoti Bio Ventures says it does not qualify as a Large Corporate; FY2026-27 initial disclosure not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cd751eb1-434a-41f6-aca8-a212a20d1dc8.pdf) |
| 30 Apr - Arunjyoti Bio Ventures confirms it is not a Large Corporate under SEBI debt disclosure norms for FY2025-26. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Arunjyoti Bio Ventures confirms it is not a Large Corporate under SEBI debt disclosure norms for FY2025-26.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b3b7729c-9b1b-4ecf-852f-3cc14d48ee43.pdf) |
| 30 Apr - Arunjyoti Bio Ventures confirms it is not a Large Corporate under SEBI debt disclosure norms for FY2025-26. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Arunjyoti Bio Ventures confirms it is not a Large Corporate under SEBI debt disclosure norms for FY2025-26.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b3b7729c-9b1b-4ecf-852f-3cc14d48ee43.pdf) |
| 3 Feb - Unaudited Q3/9M results to 31-Dec-2025: Revenue ₹648.01L, PAT ₹4.87L, limited review. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 03.02.2026 3 Feb - Unaudited Q3/9M results to 31-Dec-2025: Revenue ₹648.01L, PAT ₹4.87L, limited review.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e59ff9e7-ca4a-41a4-85dc-09ee0e447faa.pdf) |
| 23 Feb - Analyst meeting at Arihant Capital’s Bharat Connect Rising Stars conference on March 9, 2026; Bengaluru; virtual. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Feb - Analyst meeting at Arihant Capital’s Bharat Connect Rising Stars conference on March 9, 2026; Bengaluru; virtual.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce48ceed-cb2a-4873-bf66-7d26adfeb386.pdf) |
| 20 Feb - NCLT order dated Feb 13, 2026 approving Aureustech amalgamation; certified copy received Feb 20, 2026. | [Receipt Of Certified True Copy Of First Motion Order By Hon''ble NCLT, Bengaluru Bench 20 Feb - NCLT order dated Feb 13, 2026 approving Aureustech amalgamation; certified copy received Feb 20, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/37b3c4a8-38e8-446c-8fac-8da70b586195.pdf) |
| 14h - Revises FY27 growth expectation from 10% to 12.5% on AI First momentum; aims 15% for FY28. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 14h - Revises FY27 growth expectation from 10% to 12.5% on AI First momentum; aims 15% for FY28.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a998d90f-1058-4f44-879f-e8318144f98f.pdf) |
| 13 Jan - SEBI Reg.74(5) compliance certificate for quarter ended 31.12.2025; no demat/remat activity. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Jan - SEBI Reg.74(5) compliance certificate for quarter ended 31.12.2025; no demat/remat activity.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f5128c4e-c43e-47f9-9af8-0ad40e31159a.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d6fb6fdb-c37f-4a09-9c71-ece7499b526c.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e74cdd7f-616d-4a4d-8cd9-f55d5679d1ed.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fe71c4ed-ddbf-49f6-a4a2-2fee20c2f2bb.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca2f60e0-f21d-45dd-b897-5ad67efa73f2.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c7d47ad-2c06-4cb4-83af-d7e007405e89.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90126d66-a069-483c-81bf-ffa8ef810641.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04d792cd-7b16-4b41-8031-2a93f9ac7760.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543227/73129543227_08_06_22.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/530881/75978530881.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/543227/68552543227.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6322a2ad-dc65-4515-b731-ff5e28233e1a.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2db27b3-7e58-4d1e-add0-d84835e043a2.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0d570544-453a-4030-83f0-55d4b2e48c24.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f93dc05-3afe-4417-a0ba-30e9507ae47d.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bea07c5b-5f11-4483-8658-f14b76760e89.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c0a47da-d459-4bc0-946c-46506df44144.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fd1484c8-739b-4e40-8ebd-9a44a3cb3d59.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/548d9b7b-62de-49e6-be4f-fc9cf152cafd.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0e6adab4-85d1-433b-aa21-103ecbbe9f1c.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7e42dc7d-2221-46e3-8e02-fb94d279f25d.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:51:51.188Z.